Search Results 2201-2210 of 13642 for monoclonal antibody
Participation eligibility · Known history of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric, human, or humanized antibodies or ...
* High AAV9 neutralizing antibody titer. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 01/28/2026. Questions ...
The purpose of this study is to determine the safety and efficacy of intrathecal treatment delivered to the cerebrospinal fluid (CSF) of mesenchymal stem cells ...
... antibody 6. History of clinically significant bleeding event within 30 days before the first dose of study drug or need for therapeutic anticoagulation on ...
... antibody (ANCA) associated vasculitis using primary samples and/or patient derived xenograft models. Participation eligibility. Participant eligibility ...
The vaccine works by causing your body to produce its own protection (antibodies) against the disease. Meningococcal infection can cause life-threatening ...
A history of antidrug antibody formation. Inadequately controlled heart disease (New York Heart Association Classification 3 or 4) and/or known to have left ...
ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can ...
Mayo Clinic launches neutralizing antibody test to advance COVID-19 therapies featured image. Individualized Medicine. Mayo Clinic launches neutralizing ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.